Canadian Ebola vaccine development taken over by Merck
Monday, November 24, 2014 - 13:00
in Health & Medicine
Merck & Co Inc says it will buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine against the Ebola virus.